Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,606 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients

NCT03464916

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Mayo Clinic Minnesota Rochester, Minnesota, United States
  • Icahn School of Medicine New York, United States
  • University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01989598

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Foothills Hospital Calgary, Alberta, Canada
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
View Trial Details
Completed

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

NCT01583283

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States
View Trial Details
Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

NCT03697629

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details

Related conditions